Patents by Inventor James B. Pierce

James B. Pierce has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • BLIND FASTENER AND METHOD OF INSTALLATION THEREOF
    Publication number: 20240133409
    Abstract: The present disclosure relates to a blind fastener and a method of installation thereof. The blind fastener comprises a sleeve and a mandrel. The sleeve comprises a first sleeve end, a second sleeve end, and a cavity extending from the first sleeve end to the second sleeve end. The mandrel is configured to be at least partially received by the cavity of the sleeve. The mandrel comprises a first mandrel end disposed adjacent to the first sleeve end and comprising an enlarged portion having a diameter greater than a diameter of the cavity, a second mandrel end comprising a pull region, and a shank region extending intermediate the first mandrel end and the second mandrel end. The pull region comprises an axial length no greater than four times a diameter of the shank region and is configured to be engaged by an installation tool.
    Type: Application
    Filed: January 4, 2024
    Publication date: April 25, 2024
    Inventors: Robert B. Wilcox, James Thomas Smith, Troy Don Pierce
  • Method for treating retroviral infections
    Patent number: 7064139
    Abstract: Compositions and methods of treating a retroviral infection in an afflicted host and/or inhibiting replication of a retrovirus involve administering a therapeutically effective amount of the following compound of formula I: A-L-B??(I) wherein A is a substituted or unsubstituted aryl compound, substituted or unsubstituted piperidyl, or substituted or unsubstituted thiopheneyl; L is sulfonyl, sulfinyl or thio; and B is a substituted or unsubstituted aromatic nitrogen containing heteroaryl compound; or pharmacologically acceptable acid-addition and base-addition salts thereof.
    Type: Grant
    Filed: October 29, 2001
    Date of Patent: June 20, 2006
    Assignee: Uniroyal Chemical Company, Inc.
    Inventors: John A. Lacadie, James B. Pierce
  • Method for treating retroviral infections
    Publication number: 20040204451
    Abstract: Compositions and methods of treating a retroviral infection in an afflicted host and/or inhibiting replication of a retrovirus involve administering a therapeutically effective amount of the following compound of formula I:
    Type: Application
    Filed: December 19, 2003
    Publication date: October 14, 2004
    Applicant: UNIROYAL CHEMICAL COMPANY, INC., a corporation of the State of Delaware
    Inventors: John A. Lacadie, James B. Pierce
  • Method for treating retroviral infections
    Publication number: 20040132778
    Abstract: Compositions and methods of treating a retroviral infection in an afflicted host and/or inhibiting replication of a retrovirus involve administering a therapeutically effective amount of the following compound of formula I:
    Type: Application
    Filed: December 19, 2003
    Publication date: July 8, 2004
    Applicant: UNIROYAL CHEMICAL COMPANY INC., a corporation of the State of Delaware
    Inventors: John A. Lacadie, James B. Pierce
  • Method for treating retroviral infections
    Publication number: 20030139445
    Abstract: Compositions and methods of treating a retroviral infection in an afflicted host and/or inhibiting replication of a retrovirus involve administering a therapeutically effective amount of the following compound of formula I:
    Type: Application
    Filed: October 29, 2001
    Publication date: July 24, 2003
    Inventors: John A. Lacadie, James B. Pierce
  • Antiretroviral compounds and compositions
    Patent number: 6498254
    Abstract: Certain pyridine and quinoline derivatives' which inhibit replication of the retroviruses HIV-1, HIV-2 and human cytomegalovirus (HCMV) are provided. Pharmaceutical compositions useful in methods of treating or inhibiting certain retrovirus infections are described.
    Type: Grant
    Filed: October 29, 2001
    Date of Patent: December 24, 2002
    Assignee: Uniroyal Chemical Company, Inc.
    Inventors: Arthur D. Brewer, Stephen E. Cantor, Mark A. Dekeyser, Arthur M. P. Doweyko, John W. Harris, John A. Lacadie, James B. Pierce, Howard L. Plant, William A. Harrison